Our Technology

Inspire Therapy: A Treatment for People Unable to Use CPAP

When left untreated, Obstructive Sleep Apnea (OSA) can contribute to an overall diminished quality of life that includes morning headaches, daytime sleepiness, and depression. OSA may also lead to significant comorbidities such as high blood pressure, heart disease, and stroke.

Treatment options for OSA include lifestyle changes, continuous positive airway pressure (CPAP), oral appliances, and anatomy altering surgery. While CPAP is the most common form of OSA treatment, studies show between 39%-50% of OSA patients are unable to use or adhere to the treatment.2-4 Of these patients, a small subset seeks surgical treatment.

Obstructive Sleep Apnea is a prevalent health issue that affects an estimated 18 million Americans.

Inspire therapy is a fully implanted system that senses breathing patterns and deliver mild stimulation to maintain multi-level airway patency during sleep.
Conventional OSA surgery seeks to make the airway larger by removing or altering facial and airway anatomy. These anatomy altering surgeries can be effective but often involve long and painful recovery times.

Now, there is a new treatment, approved by the FDA, for patients with moderate to severe OSA who are unable to use CPAP. Inspire therapy is a fully implanted system that delivers mild stimulation to maintain multilevel airway patency during sleep.

How it Works Physician Viewpoints Patient Experiences

Inspire therapy is a unique OSA treatment that is:

Less invasive than conventional OSA surgeries and preserves the natural airway anatomy
Designed to maintain airway patency at multiple levels of the airway
Clinically proven to significantly reduce sleep apnea events and improve quality of life

    1. National Sleep Foundation. Sleep apnea and sleep., Accessed June 2, 2014.
    2. Salepci B, Caglayan B, Kiral N, et al. CPAP Adherence of Patients With Obstructive Sleep Apnea. Respiratory Care. 2013;58:1467-1473.
    3. Weaver TE. Adherence to positive airway pressure therapy. Curr Opin Pulm Med. 2006;12:409-413.
    4. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5:173-178.

Comments are closed, but trackbacks and pingbacks are open.